Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
NVS Key Statistics
Stock Snapshot
Novartis(NVS) stock is priced at $131.01, giving the company a market capitalization of 280.67B. It carries a P/E multiple of 17.63 and pays a dividend yield of 2.5%.
As of 2025-12-10, Novartis(NVS) stock has fluctuated between $130.81 and $133.15. The current price stands at $131.01, placing the stock +0.2% above today's low and -1.6% off the high.
Novartis(NVS) shares are trading with a volume of 2.13M, against a daily average of 1.73M.
In the last year, Novartis(NVS) shares hit a 52-week high of $134.24 and a 52-week low of $96.06.
In the last year, Novartis(NVS) shares hit a 52-week high of $134.24 and a 52-week low of $96.06.
NVS News
Novartis AG (NYSE:NVS) on Tuesday shared results from the VAYHIT2 Phase 3 trial of ianalumab plus eltrombopag in patients with primary immune thrombocytopenia (...
Novartis (NVS) announced positive results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag in patients with primary immune thrombocytopenia...
Novartis AG (NVS) to pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases. The deal aims to c...
Analyst ratings
52%
of 29 ratingsMore NVS News
JPMorgan upgraded Novartis (NVS) to Overweight from Neutral with a price target of CHF 125, up from CHF 95. The firm adjusted ratings in the European pharma gro...